Analytical Data
-
Gene name
ompS1
- Application
-
Alternative Names
ompS1; ompS; STY2203; t0883; Outer membrane protein S1
-
Species
Salmonella typhi
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q56110
-
Expression Region
22-394aa
-
Molecular Weight
57.2 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The ompS1 gene, encoded by the outer membrane protein S1 of various bacterial species, has garnered significant attention in recent years due to its potential applications in vaccine development and as a target for antimicrobial therapies. This protein plays a crucial role in bacterial pathogenesis, aiding in adhesion, invasion, and immune evasion. Its unique structural features and surface exposure make it an attractive candidate for recombinant protein studies aimed at eliciting protective immune responses. Researchers have focused on characterizing ompS1 for its immunogenic properties, exploring its ability to induce specific antibody production in host models. Furthermore, understanding the molecular mechanisms of ompS1 can provide insights into bacterial resistance mechanisms and virulence factors. The recombinant production of ompS1 facilitates in-depth studies on its functionality and interaction with host immune systems, paving the way for innovative strategies to combat bacterial infections. Through advances in genetic engineering and protein expression systems, the optimization of ompS1 production can lead to enhanced vaccine formulations and therapeutic agents against pathogenic bacterial strains. This research underscores the importance of ompS1 not only as a potential target for drug development but also as a vital component in understanding the complexities of bacterial infections and their interactions with the host immune system. Overall, the study of ompS1 and its recombinant forms holds promise for improving our approach to infectious diseases and developing effective vaccination strategies.
